Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PLGA (poly(lactic-co-glycolic acid)) is be used to fabricate devices for drug delivery and tissue engineering applications.
Description | PLGA (poly(lactic-co-glycolic acid)) is be used to fabricate devices for drug delivery and tissue engineering applications. |
Synonyms | poly(lactic-co-glycolic acid) |
Molecular Weight | 166.129 |
Formula | C5H10O6 |
CAS No. | 34346-01-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (300.97 mM), Sonication is recommended.
H2O: 0.1 mg/mL, Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PLGA 34346-01-5 Others poly(lactic-co-glycolic acid) inhibitor inhibit